Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.
about
Physiological-dose steroid therapy in sepsis [ISRCTN36253388]Systemic Steroids in Severe Sepsis and Septic ShockCorticosteroids for treating sepsisCorticosteroids for treating severe sepsis and septic shockCorticosteroids for severe sepsis and septic shock: a systematic review and meta-analysisSurviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Blending science and compassion: the 30th educational symposium of the Society of Critical Care Medicine, San Francisco, USA, 10-14 February 2001The International Sepsis Forum's controversies in sepsis: corticosteroids should be used to treat septic shockClinical review: corticotherapy in sepsisSteroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated).Body temperature abnormalities in non-neurological critically ill patients: a review of the literatureUpdate on adrenal insufficiency in patients with liver cirrhosisCell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cellsGlucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis.Is the current management of severe sepsis and septic shock really evidence based?Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis.Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia.Septic arthritis in adults: clinical features, outcome, and intensive care requirements.Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines.The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis.Sepsis: clinical dilemmas.New rationale for glucocorticoid treatment in septic shock.Critical appraisal of therapeutic interventions in the intensive care unit: human monoclonal antibody treatment in sepsis. Journal Club of the Hamilton Regional Critical Care Group.Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shock.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineHemodynamic and cardiovascular effects of nitric oxide modulation in the therapy of septic shock.Anti-inflammatory therapies in sepsis and septic shock.Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective.New modalities in treating pneumococcal pneumonia.Eritoran: the evidence of its therapeutic potential in sepsisClinical trials of immunomodulatory therapies in severe sepsis and septic shock.The altered adrenal axis and treatment with glucocorticoids during critical illness.A Single-Center Review of Prescribing Trends and Outcomes of Corticosteroid Replacement Therapy in Critically Ill Children with Septic ShockAnimal and human models for sepsis.The use of corticosteroids in severe sepsis and acute respiratory distress syndrome.Treatment of impaired perfusion in septic shock.The hypothalamic-pituitary-adrenal axis and low-dose glucocorticoids in the treatment of septic shock.The Japanese guidelines for the management of sepsis.Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemiaDynamic pituitary-adrenal interactions in response to cardiac surgery
P2860
Q21195121-34237B97-D3E2-4695-AD75-AB354CCCC387Q22306309-26DD4824-816C-4B61-886D-B291F29FE186Q24187207-A0BBB1FD-1267-40A0-AAE6-9BBE1D084792Q24247427-9E8C2E0E-815D-4275-B4DC-44093E622941Q24562848-E0D49F97-B017-49E9-8892-F2BD4BA16AF3Q24644984-07E698BC-7A3B-47BE-B194-29165C2665E9Q24796003-FA105C47-D3CB-485A-96F4-D4FC0DF0FD71Q24797091-3E416188-8918-4FFC-8B3B-A2584D9376BBQ24805270-2FD94C81-7C73-45CD-BF35-FB9BC07DB166Q24813320-14577C0D-5D58-45B6-A5CA-0955A19FED80Q27003449-09A77FED-EC13-4068-BC74-BC377A843BFEQ27008289-1955B8DF-1C48-4640-9542-CCE7C28FFAD8Q27026350-32649A52-C9AF-413F-BFC6-99E39F5EAF41Q30655904-DB934630-2F2B-4260-9299-14B8390C44F9Q33255319-9C51027C-EA95-49E1-825F-D33AA951AD03Q33338424-20901C9D-8985-46D1-BC9F-CA4E7A0BCF5BQ33410125-945263D9-3AD1-47D8-82E0-9C0345D4932FQ33571169-B1C22FCC-629D-450B-AA72-E975469EE7AEQ33692476-DC212BAF-89F7-4E06-ACBB-89F2073AABE0Q33753248-8675399D-73B5-4470-BED5-B6883FAA77CAQ33799383-CF39EA1D-803F-4B95-9573-D9A042906DB4Q33840119-3BCBA8C5-E576-4F34-9032-7A2810768B3CQ33857147-6BFEE784-1801-461C-9DB6-F02EC8AF6646Q33901670-C64FB462-81C3-4B68-9B70-A642AFCA1500Q33974292-88368CBF-8E54-45E3-9D59-4A6F896EB08FQ34061796-28F4EAFC-4A5F-4E35-BEB4-9AC5B5207FB5Q34074976-5845B919-484F-4E80-9DB9-CF0C95162E0AQ34153235-526160E5-A4D7-4A4D-9C4C-9A373173A968Q34185386-9354DE36-6894-48D5-9833-24674CD5B25BQ34449865-E9235408-B4C5-48B8-B978-4AA5800A8D43Q34577529-3F20AC81-BC9E-4BF2-A0CC-B6A7B03BCF13Q34807379-6A25A4D7-C1BF-4395-BAD2-BE2FCB6723F4Q35034145-BF682EEB-6A19-429C-8EB8-1015E89FFCE7Q35055001-B9E54AA9-C40F-4AA4-8702-B93FF3A1598FQ35055006-A2262F83-FBCA-4188-ABEE-FB4A84B27E2AQ35055011-327A577A-4225-4010-8BF7-A0CEB346DEDFQ35101483-822486F6-FA5C-480E-9567-B87ACD044C43Q35107094-D9C1D065-541D-41AD-934F-D551D5E3D343Q35115921-145B82E2-81B5-45E3-BDF0-907FBD459F20Q35178222-C429E984-A608-4DE5-8C2B-8F548BD0844A
P2860
Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@ast
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@en
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@nl
type
label
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@ast
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@en
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@nl
prefLabel
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@ast
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@en
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@nl
P1476
Effect of high-dose glucocorti ...... ical signs of systemic sepsis.
@en
P2093
Veterans Administration Systemic Sepsis Cooperative Study Group
P304
P356
10.1056/NEJM198709103171102
P407
P577
1987-09-01T00:00:00Z